LEXXW Stock Financials: Financial Performance and Reports

Period	FY-2023	FY-2022	FY-2021	FY-2020	FY-2019	FY-2018	FY-2017	FY-2016	FY-2015	FY-2014
Period Ended	08/31/2023	08/31/2022	08/31/2021	08/31/2020	08/31/2019	08/31/2018	08/31/2017	08/31/2016	08/31/2015	08/31/2014
Operating Revenue	$226,208.00	$255,397.00	$722,738.00	$384,543.00	$222,610.00	$433,287.00	$63,639.00	$40,718.00	$14,702.00	$1.10 M
Cost of Revenue	$31,500.00	$71,841.00	$175,346.00	$99,378.00	$22,893.00	$25,185.00	$29,750.00	$45,615.00	$29,883.00	$795,204.00
Gross Profit	$194,708.00	$183,556.00	$547,392.00	$285,165.00	$199,717.00	$408,102.00	$33,889.00	-$4,897.00	-$15,181.00	$302,251.00
Gross Profit Ratio	0.86	0.72	0.76	0.74	0.9	0.94	0.53	-0.12	-1.03	0.28
Research and Development Expenses	$3.67 M	$1.84 M	$1.26 M	$387,074.00	$555,730.00	$492,864.00	$54,185.00	$9,024.00	$146,466.00	$0.00
General & Administrative Expenses	$3.06 M	$5.72 M	$4.97 M	$3.57 M	$3.13 M	$6.02 M	$1.63 M	$1.01 M	$1.49 M	$0.00
Selling & Marketing Expenses	$0.00	$0.00	$0.00	$204,277.00	$515,360.00	$489,058.00	$209,034.00	$185,459.00	$276,560.00	$8,194.00
Selling, General & Administrative Expenses	$3.06 M	$5.72 M	$4.97 M	$3.77 M	$3.64 M	$6.51 M	$1.84 M	$1.20 M	$1.76 M	$8,194.00
Other Expenses	$0.00	$0.00	$0.00	$112,750.00	$60,550.00	$2,307.00	-$886.00	$4,602.00	-$22,664.00	$0.00
Operating Expenses	$6.73 M	$7.57 M	$6.23 M	$4.27 M	$4.26 M	$7.01 M	$1.90 M	$1.21 M	$1.91 M	$8,194.00
Cost And Expenses	$6.76 M	$7.64 M	$6.41 M	$4.37 M	$4.28 M	$7.03 M	$1.92 M	$1.26 M	$1.94 M	$803,398.00
Interest Income	$43,190.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Interest Expense	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$6,015.00	$2,250.00	$31,544.00	$267,357.00
Depreciation & Amortization	$145,397.00	$141,315.00	-$1.38 M	$112,750.00	$60,550.00	$2,307.00	$1,488.00	$619.00	-$22,664.00	$0.00
EBITDA	-$6.17 M	-$7.24 M	-$7.06 M	-$3.78 M	-$3.90 M	-$6.60 M	-$1.86 M	-$1.21 M	-$1.95 M	$294,057.00
EBITDA Ratio	-27.26	-28.36	-9.77	-9.83	-17.52	-15.23	-29.22	-29.84	-132.69	0.27
Operating Income	-$6.53 M	-$7.38 M	-$5.69 M	-$3.89 M	-$3.96 M	-$6.60 M	-$1.86 M	-$1.22 M	-$1.93 M	$294,057.00
Operating Income Ratio	-28.89	-28.91	-7.87	-10.12	-17.79	-15.23	-29.25	-29.85	-131.15	0.27
Total Other Income/Expenses Net	-$221,693.00	-$764,614.00	$1.52 M	-$192,662.00	-$197,232.00	-$8,968.00	-$62,196.00	-$59,422.00	-$23,514.00	$0.00
Income Before Tax	-$6.71 M	-$7.38 M	-$4.16 M	-$4.08 M	-$4.16 M	-$6.61 M	-$1.93 M	-$1.28 M	-$1.98 M	$0.00
Income Before Tax Ratio	-29.67	-28.91	-5.76	-10.62	-18.68	-15.25	-30.32	-31.37	-134.9	0
Income Tax Expense	$130,877.00	-$114,329.00	-$1.66 M	-$54,286.00	$39,623.00	-$8,968.00	-$54,173.00	-$60,226.00	-$181,226.00	$0.00
Net Income	-$6.66 M	-$7.27 M	-$2.50 M	-$4.03 M	-$4.20 M	-$6.60 M	-$1.87 M	-$1.21 M	-$1.77 M	$0.00
Net Income Ratio	-29.46	-28.46	-3.47	-10.48	-18.86	-15.23	-29.37	-29.83	-120.43	0
EPS	-1.01	-1.24	-0.57	-1.45	-1.62	-2.79	-0.95	-0.83	-1.34	0
EPS Diluted	-1.01	-1.24	-0.57	-1.45	-1.62	-2.79	-0.95	-0.83	-1.34	0
Weighted Average Shares Out	$6.61 M	$5.89 M	$4.39 M	$2.77 M	$2.59 M	$2.37 M	$1.96 M	$1.46 M	$1.32 M	$25.71 M
Weighted Average Shares Out Diluted	$6.61 M	$5.89 M	$4.39 M	$2.77 M	$2.59 M	$2.37 M	$1.96 M	$1.46 M	$1.32 M	$25.71 M
Link

Lexaria Bioscience Corp. (LEXXW) Financials

Select an alert type

Setup alert

Log In

Email Verification

Welcome to StockNews!

Create Your Account

Email Verification